Heart failure and atrial fibrillation: current concepts and controversies.

Heart failure and atrial fibrillation are very common, particularly in the elderly. Owing to common risk factors both disorders are often present in the same patient. In addition, there is increasing evidence of a complex, reciprocal relation between heart failure and atrial fibrillation. Thus heart failure may cause atrial fibrillation, with electromechanical feedback and neurohumoral activation playing an important mediating role. In addition, atrial fibrillation may promote heart failure; in particular, when there is an uncontrolled ventricular rate, tachycardiomyopathy may develop and thereby heart failure. Eventually, a vicious circle between heart failure and atrial fibrillation may form, in which neurohumoral activation and subtle derangement of rate control are involved. Treatment should aim at unloading of the heart, adequate control of ventricular rate, and correction of neurohumoral activation. Angiotensin converting enzyme inhibitors may help to achieve these goals. Treatment should also include an attempt to restore sinus rhythm through electrical cardioversion, though appropriate timing of cardioversion is difficult. His bundle ablation may be used to achieve adequate rate control in drug refractory cases.

[1]  P. Coumel Neural aspects of paroxysmal atrial fibrillation , 1992 .

[2]  F. Solti,et al.  The effect of atrial dilatation on the genesis of atrial arrhythmias. , 1989, Cardiovascular research.

[3]  A. Weyman,et al.  Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. , 1990, Circulation.

[4]  H. Crijns,et al.  Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. , 1995, Journal of cardiac failure.

[5]  M. Brignole,et al.  Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. , 1994, The American journal of cardiology.

[6]  H. Crijns,et al.  Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. , 1993, The American journal of cardiology.

[7]  W. Heddle,et al.  Effects on Cardiac Performance of Atrioventricular Node Catheter Ablation Using Radiofrequency Current for Drug‐Refractory Atrial Arrhythmias , 1993, Pacing and clinical electrophysiology : PACE.

[8]  D. J. Veldhuisen,et al.  Reversion of tachycardiomyopathy after β-blocker , 1993, The Lancet.

[9]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[10]  E. Michelson,et al.  Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.

[11]  H. Crijns,et al.  Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease. , 1993, Journal of the American College of Cardiology.

[12]  H. Kay,et al.  Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. , 1987, The American journal of cardiology.

[13]  S. Hohnloser,et al.  Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. , 1988, American heart journal.

[14]  H. Crijns,et al.  Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation. A 2-year follow-up. , 1994, European heart journal.

[15]  H. Crijns,et al.  Chronotropic response to exercise in patients with atrial fibrillation: relation to functional state. , 1993, British heart journal.

[16]  D P Zipes,et al.  Effect of atrioventricular interval during pacing or reciprocating tachycardia on atrial size, pressure, and refractory period. Contraction-excitation feedback in human atrium. , 1990, Circulation.

[17]  H C Smith,et al.  Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. , 1992, The American journal of cardiology.

[18]  S. Vaziri,et al.  Echocardiographic Predictors of Nonrheumatic Atrial Fibrillation: The Framingham Heart Study , 1994, Circulation.

[19]  W. Kannel,et al.  Epidemiologic features of chronic atrial fibrillation: the Framingham study. , 1982, The New England journal of medicine.

[20]  J. Linden,et al.  Effect of atrial contraction frequency on atrial natriuretic peptide secretion. , 1986, The American journal of physiology.

[21]  J. Cohn,et al.  The Influence of Atrial Fibrillation on Prognosis in Mild to Moderate Heart Failure The V‐HeFT Studies , 1993, Circulation.

[22]  H. Crijns,et al.  Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. , 1991, The American journal of cardiology.

[23]  D. Levy,et al.  Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects , 1993, Circulation.

[24]  R. Kronmal,et al.  Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. , 1992, Journal of the American College of Cardiology.

[25]  A. Keogh,et al.  Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. , 1990, The American journal of cardiology.

[26]  M. Rosenqvist,et al.  Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. , 1995, British heart journal.

[27]  W G Stevenson,et al.  Prognostic Significance of Atrial Fibrillation in Advanced Heart Failure: A Study of 390 Patients , 1991, Circulation.

[28]  W. Lewis,et al.  Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure. , 1994, The American journal of cardiology.

[29]  J. Langberg,et al.  Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. , 1990, Journal of the American College of Cardiology.

[30]  G. Heinz,et al.  Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. , 1992, The American journal of cardiology.

[31]  G. Francis,et al.  Hemodynamic and neurohumoral responses to dynamic exercise: normal subjects versus patients with heart disease. , 1987, Circulation.

[32]  H. Buikema,et al.  Hyperactive tissue renin-angiotensin systems in cardiovascular dysfunction: experimental evidence and clinical hypotheses. , 1995, Clinical and experimental hypertension.

[33]  T. Takano,et al.  Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: endocrinologic silence. , 1991, Journal of the American College of Cardiology.

[34]  H. Wellens,et al.  Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. , 1993, The American journal of cardiology.